about
A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447]Molecular epidemiology of HIV type 1 in a rural community in southwest UgandaHelminth infection is not associated with faster progression of HIV disease in coinfected adults in UgandaHerpes zoster and HIV-1 infection in a rural Ugandan cohort.Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisationSurvival by AIDS defining condition in rural Uganda.Aetiology of sexually transmitted infections and response to syndromic treatment in southwest UgandaSeroprevalence and incidence of genital ulcer infections in a rural Ugandan population.Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.Human immunodeficiency virus (HIV) in developing countries.Strengthening capacity to apply health research evidence in policy making: experience from four countries.Is sexual risk taking behaviour changing in rural south-west Uganda? Behaviour trends in a rural population cohort 1993-2006Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial.A community randomized controlled trial to investigate impact of improved STD management and behavioural interventions on HIV incidence in rural Masaka, Uganda: trial design, methods and baseline findings.Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study.Women who fall by the roadside: gender, sexual risk and alcohol in rural Uganda.Sexual partner types and related sexual health risk among out-of-school adolescents in rural south-west Uganda.Association between active GB virus-C (hepatitis G) infection and HIV-1 disease in Uganda.A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda.Changing association between schooling levels and HIV-1 infection over 11 years in a rural population cohort in south-west Uganda.Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.Sexually transmitted disease management in Uganda's private-for-profit formal and informal sector and compliance with treatment.Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.Dental treatment needs of children in a rural subcounty of Uganda.Community sex education among adolescents in rural Uganda: utilizing indigenous institutions.Screening for intestinal helminth infestation in a semi-urban cohort of HIV-infected people in Uganda: a combination of techniques may enhance diagnostic yield in the absence of multiple stool samples.Social marketing of pre-packaged treatment for men with urethral discharge (Clear Seven) in Uganda.Men's attitudes to condoms and female controlled means of protection against HIV and STDs in south-western Uganda.Evaluation of E-optotypes as a screening test and the prevalence and causes of visual loss in a rural population in SW Uganda.Absence of a recognizable seroconversion illness in Africans infected with HIV-1.Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.The natural history of HIV-1 infection in Africa.Risk perception and HIV-1 prevalence in 15,000 adults in rural south-west Uganda.Type of partnership and heterosexual spread of HIV infection in rural Uganda: results from simulation modelling.Ocular findings in HIV-1 positive and HIV-1 negative participants in a rural population-based cohort in Uganda.Reduced fertility associated with HIV: the contribution of pre-existing subfertility.Causes and prevalence of non-vision impairing ocular conditions among a rural adult population in sw Uganda.HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan population.Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.Early manifestations (pre-AIDS) of HIV-1 infection in Uganda.
P50
Q25257302-1C7F3D8A-250D-4331-88DE-A1E188B0FFD4Q28142366-E4AB4281-2D67-435E-BF2C-3ADDFF98AB9BQ28289175-E6025D84-12C0-4058-81AC-D2E08C0B177FQ33935432-E74859FA-99DF-4C68-A94C-F77F79868FF0Q34491123-44775048-E223-4A3E-BD24-FBDEAFE72252Q35528529-3FE902D2-FF39-49ED-9126-B2B4EA6724D5Q35532012-8D4B0C61-75D3-49D2-BF3E-407B8C5887A3Q35562429-F228AFE3-9756-4D27-A4C1-03D1B68E1EDEQ36331074-83A377B8-4B32-4E55-A233-F8490C412E42Q36561178-E840FCD3-E4CE-4545-B895-B3062E12BB97Q36564732-8931FF37-A18D-4CF7-A955-59929BE08288Q37124313-1300C8DC-AC06-4317-8316-F4B4B4D373D2Q37870046-589C2915-4AC6-4175-87C1-0847BE6800BBQ37870711-14B94ACF-54A8-47FA-BA0A-6671B4950B01Q38488424-E19BA399-9401-4B8A-9A91-EA0448F9728FQ38552665-B9361547-22DB-404A-8F99-258C27F27FF8Q38870938-69BB5ED1-DC87-467F-AE03-22C66E66B0F9Q38878059-F1117464-B48C-46FD-A644-7B8348348A2FQ38880198-31147452-2A6F-4979-A28F-5F3A7A20AAA9Q38880378-C45C5EF8-DF47-461C-9770-2132DF3F9947Q38881013-FB21BBE4-5532-4059-8E77-5BDB998DF08DQ38881578-FA86FA7D-9DC1-42F5-A122-96FB4A80D42CQ38881896-CE6770F4-0E2B-4791-AD7E-BF35DDDFA2C4Q38882460-431540C7-B997-4B0F-A12F-7CA13ED7ABD2Q38882538-DCE579C2-E34A-46BD-AC37-BFFE117BD72EQ38883317-01B88E22-7F9D-407B-8BDF-8EF837A6224EQ38883348-93E83EC9-F21F-48ED-B766-D9FF56D0415EQ38883926-3A2D342D-AC4E-44F0-9903-3650CE1529E2Q38884132-74220DF2-A8DD-4C94-854B-5F8D543531D6Q38885027-26FC85EC-E7F2-4736-BDB1-AFD12E7B7FDCQ38885142-26C84510-0AB6-4A28-9ECC-D8579178E894Q38885535-5B3F4405-025A-4924-9BC0-5BB8D5BD2004Q38886344-CD2079F6-E2C7-49C6-9FC2-5E2B816A8BE7Q38886350-D23D761E-3D54-4661-8E86-29D65EEEC271Q38886372-9771C982-A987-4AA6-83C4-EBA0ED3EEAA6Q38886383-4AA1E765-20F0-4821-ADC9-4F52912AE7D3Q38886711-F583EBFF-802D-456A-B152-3C7524EC06B4Q38886873-247E51CF-D76B-45BB-9C4F-9BCAEABA2395Q38887128-DF5639F5-7621-4D03-BD38-78FD1465E94FQ38887410-A3CB9D62-A041-4A16-B7D8-9CBFF6A7D9D8
P50
description
researcher
@en
name
J A Whitworth
@en
J A Whitworth
@nl
type
label
J A Whitworth
@en
J A Whitworth
@nl
prefLabel
J A Whitworth
@en
J A Whitworth
@nl
P106
P31
P496
0000-0002-0234-8065